版本:
中国

BRIEF-EMA recommends conditional approval of Abbvie leukemia drug

Oct 14 European Medicines Agency(EMA):

* EU Medicines Agency recommendations for October 2016

* EU Medicines Agency recommends approval of Abbvie Inc'S Venetoclax/Venclexta to treat leukaemia

* EU Medicines Agency recommends conditional marketing approval of Intercept Pharmaceuticals Inc'S Ocaliva to treat primary biliary cirrhosis Link to source: (bit.ly/2dYKT7R) (Bengaluru Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐